Evvy Raised $40 Million For Data On Women's Bodies To Fill Scientific Gap
Evvy raised a $40 million Series B for vaginal microbiome testing data.
CEO Priyanka Jain explains why the genomes stay private and who ends up owning them.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.forbes.com — the content belongs to Forbes.